Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VolitionRX ( (VNRX) ) just unveiled an announcement.
At a special meeting held on March 31, 2026, VolitionRx stockholders authorized the board of directors to implement a reverse stock split of the company’s common shares at a ratio to be set within an approved range. The board subsequently selected a one-for-twenty ratio, consolidating every twenty existing common shares into a single share.
On April 27, 2026, VolitionRx filed a Certificate of Third Amendment to its Second Amended and Restated Certificate of Incorporation with the Delaware Secretary of State, effective 12:01 a.m. ET on April 28, 2026, to formally enact the one-for-twenty reverse stock split and specify how fractional shares would be treated. The move restructures the company’s share capital and may influence its share price level and market perception by reducing the number of outstanding common shares.
The most recent analyst rating on (VNRX) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on VolitionRX stock, see the VNRX Stock Forecast page.
Spark’s Take on VNRX Stock
According to Spark, TipRanks’ AI Analyst, VNRX is a Neutral.
The score is held down primarily by weak financial performance (persistent losses, cash burn, and negative equity). The earnings call adds support via improving cost discipline, strong percentage revenue growth, and partnership/scientific momentum, but technical indicators remain mixed and valuation is difficult to assess due to negative earnings.
To see Spark’s full report on VNRX stock, click here.
More about VolitionRX
VolitionRx Limited operates in the life sciences sector, focusing on the development and commercialization of diagnostic technologies, with its shares listed as common stock with a par value of $0.001. The company’s corporate structure is governed by its Amended and Restated Certificate of Incorporation, which it periodically updates to reflect capital structure changes approved by stockholders.
Average Trading Volume: 11,386,951
Technical Sentiment Signal: Sell
Current Market Cap: $22.2M
Find detailed analytics on VNRX stock on TipRanks’ Stock Analysis page.